Status:
TERMINATED
Oral Pregabalin as Preemptive Analgesia in Abdominal Hysterectomy
Lead Sponsor:
Universidade Federal de Alfenas
Conditions:
Pain, Postoperative
Analgesia
Eligibility:
FEMALE
20-65 years
Phase:
PHASE4
Brief Summary
Postoperative pain affects 80% of surgical patients and is one of the main negative symptoms resulting from surgery. It impairs the recovery of patient since it is related to chronic pain, nausea and ...
Detailed Description
The sample population of this study is 102 female patients (50 already included in the study), who have undergone abdominal hysterectomy surgery for benign conditions, with or without joint oophorecto...
Eligibility Criteria
Inclusion
- Patients who will undergo elective abdominal hysterectomy surgery due to benign pathologies;
- Be classified as physical status by the Society of Anesthesiologists (ASA) as ASA I (healthy individual) or ASA II (patient with mild and controlled systemic disease);
Exclusion
- Allergy or intolerance previously known to pregabalin or opioids;
- Patients with chronic pain or fibromyalgia;
- Patients on chronic opioid use;
- Carriers of malignant neoplasms;
- Pregnant women;
- People with active uncontrolled cardiovascular disease;
- Patients with kidney and / or liver disease;
- Patients who have spinal deformities that make spinal anesthesia impossible;
- Presence of coagulation disorders or anticoagulant therapy that cannot be suspended for surgery;
- Presence of active sepsis.
Key Trial Info
Start Date :
September 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04495374
Start Date
September 2 2019
End Date
September 30 2020
Last Update
March 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade Federal de Alfenas
Alfenas, Minas Gerais, Brazil, 37130-001